resveratrol has been researched along with simvastatin in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 8 (61.54) | 24.3611 |
| 2020's | 3 (23.08) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Sashidhara, KV; Singh, SP | 1 |
| Beronov, K; Cicha, I; Daniel, WG; Garlichs, CD; Goppelt-Struebe, M; Osterode, K; Raaz, D; Ramirez, EL; Yilmaz, A | 1 |
| Astle, CM; Baur, JA; Boyd, AR; de Cabo, R; Fernandez, E; Flurkey, K; Harrison, DE; Javors, MA; Miller, RA; Nadon, NL; Nelson, JF; Orihuela, CJ; Pletcher, S; Sharp, ZD; Sinclair, D; Starnes, JW; Strong, R; Wilkinson, JE | 1 |
| Bereswill, S; Fischer, A; Göbel, UB; Haag, LM; Heimesaat, MM; Kühl, AA; Loddenkemper, C; Muñoz, M; Otto, B; Plickert, R | 1 |
| Cress, AB; Duleba, AJ; Ortega, I; Sokalska, A; Villanueva, JA; Wong, DH | 1 |
| Bruner-Tran, KL; Cress, AB; Duleba, AJ; Ortega, I; Osteen, KG; Sokalska, A; Villanueva, JA | 1 |
| Dinesh, N; Kaur, PK; Kishore Babu, N; Pallerla, DS; Singh, S | 1 |
| Cress, AB; Duleba, AJ; Ortega, I; Sokalska, A; Stanley, SD; Villanueva, JA; Wong, DH | 1 |
| Fišar, Z; Hroudová, J; Kopřivová, A; Macečková, D; Singh, N | 1 |
| Attalah Nee Rezkallah, C; Chen, QM; Thongkum, A; Zhu, C | 1 |
| Imanaka, S; Kimura, M; Kobayashi, H; Maruyama, S; Nagayasu, M | 1 |
| Hartmann, D; Kassumeh, S; Ohlmann, A; Priglinger, SG; Strehle, L; Tersi, N; Wertheimer, CM; Wolf, A | 1 |
2 review(s) available for resveratrol and simvastatin
| Article | Year |
|---|---|
Lipid lowering agents of natural origin: An account of some promising chemotypes.
Topics: Animals; Biological Products; Dyslipidemias; Humans; Hypolipidemic Agents | 2017 |
Nonhormonal Treatment for Endometriosis Focusing on Redox Imbalance.
Topics: Animals; Antioxidants; Cabergoline; Dopamine Agonists; Endometriosis; Female; Glucosides; Humans; Methemoglobin; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; Resveratrol; Signal Transduction; Simvastatin; Stilbenes; Superoxides | 2021 |
11 other study(ies) available for resveratrol and simvastatin
| Article | Year |
|---|---|
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Shear stress preconditioning modulates endothelial susceptibility to circulating TNF-alpha and monocytic cell recruitment in a simplified model of arterial bifurcations.
Topics: Anti-Inflammatory Agents; Atherosclerosis; Cell Adhesion; Cell Culture Techniques; Cells, Cultured; Computer Simulation; E-Selectin; Endothelial Cells; Fluorescent Antibody Technique; Humans; Models, Cardiovascular; Monocytes; NF-kappa B; Numerical Analysis, Computer-Assisted; Resveratrol; Simvastatin; Stilbenes; Stress, Mechanical; Stress, Physiological; Time Factors; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2009 |
Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice.
Topics: Aging; Animals; Female; Genetic Heterogeneity; Longevity; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Resveratrol; Simvastatin; Sirolimus; Stilbenes | 2011 |
Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Curcumin; Disease Models, Animal; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ileitis; Inflammation; Intestine, Small; Mice; Mice, Inbred C57BL; Resveratrol; Simvastatin; Stilbenes; Th1 Cells; Toxoplasma | 2010 |
Resveratrol inhibits the mevalonate pathway and potentiates the antiproliferative effects of simvastatin in rat theca-interstitial cells.
Topics: Animals; Blotting, Western; Cell Proliferation; Cells, Cultured; Cholesterol; DNA Replication; Dose-Response Relationship, Drug; Drug Synergism; Female; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Polyisoprenyl Phosphates; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Sesquiterpenes; Simvastatin; Stilbenes; Theca Cells | 2011 |
Resveratrol potentiates effect of simvastatin on inhibition of mevalonate pathway in human endometrial stromal cells.
Topics: Acetates; Adult; Anti-Inflammatory Agents, Non-Steroidal; Carbon Radioisotopes; Cholesterol; Drug Synergism; Endometrium; Female; Gene Expression Regulation, Enzymologic; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Primary Cell Culture; Resveratrol; RNA, Messenger; Simvastatin; Stilbenes; Stromal Cells | 2013 |
Exploring Leishmania donovani 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) as a potential drug target by biochemical, biophysical and inhibition studies.
Topics: Amino Acid Sequence; Atorvastatin; Cholesterol; Cloning, Molecular; DNA, Protozoan; Drug Delivery Systems; Ergosterol; Gene Expression Regulation, Enzymologic; Genes, Protozoan; Heptanoic Acids; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leishmania donovani; Molecular Sequence Data; Open Reading Frames; Protein Structure, Secondary; Pyrroles; Recombinant Proteins; Resveratrol; Sequence Analysis, DNA; Simvastatin; Stilbenes | 2014 |
Resveratrol potentiates effects of simvastatin on inhibition of rat ovarian theca-interstitial cells steroidogenesis.
Topics: Androstenedione; Androsterone; Animals; Cells, Cultured; Dose-Response Relationship, Drug; Down-Regulation; Drug Synergism; Female; Gene Expression Regulation, Enzymologic; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Rats, Sprague-Dawley; Resveratrol; RNA, Messenger; Simvastatin; Steroid 17-alpha-Hydroxylase; Stilbenes; Theca Cells; Time Factors | 2014 |
Effect of Simvastatin, Coenzyme Q10, Resveratrol, Acetylcysteine and Acetylcarnitine on Mitochondrial Respiration.
Topics: Acetylcarnitine; Acetylcysteine; Animals; Brain; Cell Respiration; Electron Transport Complex IV; Mitochondria; Neuroprotective Agents; Oxygen Consumption; Resveratrol; Simvastatin; Stilbenes; Swine; Ubiquinone | 2016 |
Resveratrol for protection against statin toxicity in C2C12 and H9c2 cells.
Topics: Animals; Atorvastatin; Caspase 3; Caspase 7; Cell Line; Cell Survival; Fluvastatin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Mice; Myoblasts; Pravastatin; Protective Agents; Rats; Resveratrol; Signal Transduction; Simvastatin | 2020 |
Pharmacological Therapy of Proliferative Vitreoretinopathy: Systematic
Topics: Dasatinib; Humans; Resveratrol; Retinal Pigment Epithelium; Simvastatin; Vitreoretinopathy, Proliferative | 2023 |